Military study on wegovy for obesity pulled before start
NCT ID NCT06468748
First seen Dec 29, 2025 · Last updated May 08, 2026 · Updated 16 times
Summary
This study aimed to see if the weight-loss drug Wegovy (semaglutide) could help active-duty military personnel with obesity lose weight and improve body composition and physical performance. It planned to follow participants for 24 weeks on the drug and then 52 weeks off it. However, the study was withdrawn before enrolling anyone, so no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
USARIEM
Natick, Massachusetts, 01760, United States
Conditions
Explore the condition pages connected to this study.